全球移植藥物監測分析市場報告

預計到 2030 年，全球移植藥物監測檢測市場的市場規模將從 2022 年的 212.72 萬美元達到近 645.2 萬美元，2023-2030 年研究期間的年複合成長率為 13.12%。

移植藥物監測測定對於幫助醫療保健專業人員將免疫抑制劑的血漿和血液水平維持在各自的治療範圍內至關重要。移植藥物監測測定從開始用藥開始。它包括確定患者可接受的初步劑量方案和臨床狀態特徵，例如年齡、體重指數、體重、器官功能和藥物治療。

市場動態：

推動市場成長的因素包括器官移植需求的增加、研發資金的增加以及腎臟疾病等慢性病盛行率的增加。此外，在預測期內，對床邊治療藥物監測和家庭治療藥物監測的需求增加可能為全球移植藥物監測分析產業的參與者提供利潤豐厚的市場機會。此外，醫療保健支出的增加、醫療保健基礎設施的改善、全球人均收入的增加以及政府報銷計劃預計將在未來幾年為移植藥物監測檢測市場帶來盈利前景。然而，需要巨額投資以及小型醫院不願提供移植藥物監測檢測服務可能會阻礙市場成長。

研究報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰地了解行業結構並評估全球範圍內的競爭吸引力。此外，這些工具還對全球移植藥物監測分析市場的每個細分市場進行了包容性評估。移植藥物監測分析產業的成長和趨勢為這項研究提供了整體方法。

區域分析：

本節涵蓋區域前景，重點介紹北美、歐洲、亞太地區、拉丁美洲以及中東和非洲移植藥物監測檢測市場當前和未來的需求。此外，該報告重點關注所有主要地區各個應用領域的需求、估計和預測。

該研究報告還涵蓋了市場主要參與者的全面概況以及對全球競爭格局的深入了解。移植藥物監測檢測市場的主要參與者包括 Abbott、Thermo Fisher Scientific Inc.、HU Group Holdings Inc. (Fujirebio Holdings, Inc.)、Hoffmann-La Roche Ltd.、Siemens Healthineers AG、Hologic Inc.、Danaher Corporation、 Bio -Rad Laboratories Inc.，其他知名企業。本節包含競爭格局的整體視圖，包括各種策略發展，例如關鍵併購、未來產能、合作夥伴關係、財務概況、合作、新產品開發、新產品發布和其他發展。

如果您有任何客製化要求，請寫信給我們。我們的研究團隊可以根據您的需求提供客製化報告。

目錄

第 1 章：前言

• 報告說明
  • 客觀的
  • 目標受眾
  • 獨特的銷售主張 (USP) 和產品
• 研究範圍
• 研究方法論
  • 市場研究過程
  • 市場研究方法論

第 2 章：執行摘要

• 市場亮點
• 全球市場概況

第 3 章：移植藥物監測分析 - 產業分析

• 簡介 - 市場動態
• 市場促進因素
• 市場限制
• 機會
• 產業動態
• 波特五力分析
• 市場吸引力分析
  • 按產品分類的市場吸引力分析
  • 按技術分類的市場吸引力分析
  • 藥品市場吸引力分析
  • 最終用戶的市場吸引力分析
  • 市場吸引力分析：按地區

第 4 章：價值鏈分析

• 價值鏈分析
• 原料分析
  • 原料清單
  • 原料廠商清單
  • 主要原物料價格走勢
• 潛在買家名單
• 行銷管道
  • 直效行銷
  • 間接行銷
  • 行銷通路發展趨勢

第 5 章：COVID-19 爆發的影響分析

第 6 章：全球移植藥物監測分析市場分析：副產品

• 按產品概述
• 歷史和預測數據
• 按產品分析
• 裝置
• 耗材（色譜和 MS 檢測器、免疫分析儀、臨床化學分析儀）

第 7 章：全球移植藥物監測分析市場分析：依技術分類

• 依技術概述
• 歷史和預測數據
• 依技術分析
• 色譜-質譜
• 免疫測定

第 8 章：全球移植藥物監測分析市場分析：依藥物分類

• 按藥物概述
• 歷史和預測數據
• 藥物分析
• 他克莫司
• 甲胺蝶呤
• 環孢菌素
• 其他

第 9 章：全球移植藥物監測分析市場分析：依最終使用者分類

• 最終用戶概述
• 歷史和預測數據
• 最終用戶分析
• 醫院實驗室
• 商業和私人實驗室
• 其他

第 10 章：全球移植藥物監測分析市場分析：依地理位置

• 區域展望
• 介紹
• 北美銷售分析
  • 概述、歷史和預測銷售分析
  • 北美按細分市場銷售分析
  • 北美按國家銷售分析
  • 美國銷售分析
  • 加拿大銷售分析
  • 墨西哥銷售分析
• 歐洲銷售分析
  • 概述、歷史和預測銷售分析
  • 歐洲按細分市場銷售分析
  • 歐洲按國家銷售分析
  • 英國銷售分析
  • 法國銷售分析
  • 德國銷售分析
  • 義大利銷售分析
  • 俄羅斯銷售分析
  • 歐洲其他地區銷售分析
• 亞太地區銷售分析
  • 概述、歷史和預測銷售分析
  • 亞太地區按細分市場銷售分析
  • 亞太地區國家/地區銷售分析
  • 中國銷售分析
  • 印度銷售分析
  • 日本銷售分析
  • 韓國銷售分析
  • 澳洲銷售分析
  • 亞太地區其他地區銷售分析
• 拉丁美洲銷售分析
  • 概述、歷史和預測銷售分析
  • 拉丁美洲按細分市場銷售分析
  • 拉丁美洲按國家銷售分析
  • 巴西銷售分析
  • 阿根廷銷售分析
  • 秘魯銷售分析
  • 智利銷售分析
  • 拉丁美洲其他地區銷售分析
• 中東和非洲銷售分析
  • 概述、歷史和預測銷售分析
  • 中東和非洲按細分市場銷售分析
  • 中東和非洲國家銷售分析
  • 沙烏地阿拉伯銷售分析
  • 阿拉伯聯合大公國銷售分析
  • 以色列銷售分析
  • 南非銷售分析
  • 中東其他地區和非洲銷售分析

第 11 章：移植藥物監測分析公司的競爭格局

• 移植藥物監測分析市場競爭
• 夥伴關係/協作/協議
• 併購
• 新產品發布
• 其他發展

第 12 章：公司簡介

• 頂尖公司股票分析
• 市場集中度
• Abbott
• 公司簡介
• 公司收入
• 產品
• 最近的發展
• Thermo Fisher Scientific Inc.
• 公司簡介
• 公司收入
• 產品
• 最近的發展
• HU Group Holdings Inc.
• 公司簡介
• 公司收入
• 產品
• 最近的發展
• Fujirebio Holdings Inc.
• 公司簡介
• 公司收入
• 產品
• 最近的發展
• Hoffmann-La Roche Ltd.
• 公司簡介
• 公司收入
• 產品
• 最近的發展
• Siemens Healthineers AG
• 公司簡介
• 公司收入
• 產品
• 最近的發展
• Hologic Inc.
• 公司簡介
• 公司收入
• 產品
• 最近的發展
• Danaher Corporation
• 公司簡介
• 公司收入
• 產品
• 最近的發展
• Bio-Rad Laboratories Inc.
• 公司簡介
• 公司收入
• 產品
• 最近的發展
• Other Prominent Players
• 公司簡介
• 公司收入
• 產品
• 最近的發展

注意 - 在公司概況中，財務詳細資訊和近期發展視情況而定，或者如果是私人公司，則可能不包括在內

The global demand for Transplant Drug Monitoring Assay Market is presumed to reach the market size of nearly USD 645.2 MN by 2030 from USD 212.72 MN in 2022 with a CAGR of 13.12% under the study period 2023 - 2030.

Transplant drug monitoring assay is crucial in helping health care professionals maintain plasma and blood levels of immunosuppressants within their respective therapeutic ranges. Transplant drug monitoring assay starts with the initiation of medication. It includes the determination of a preliminary dosage regimen acceptable for the patient and clinical state characteristics such as age, body mass index, weight, organ function and drug therapy.

MARKET DYNAMICS:

The factors fueling the market growth are the increased demand for organ transplants, increased R&D funding, and an increase in the prevalence of chronic diseases such as kidney diseases. Moreover, an increase in the need for point-of-care therapeutic drug monitoring and home-based therapeutic drug monitoring is likely to offer lucrative market opportunities for players operating in the global transplant drug monitoring assay industry during the forecast period. Additionally, a rise in healthcare expenditure, improvement in healthcare infrastructure, increase in global per capita income, and government reimbursement programs are projected to present profitable prospects in the transplant drug monitoring assay market in the upcoming years. However, the need for huge investments and the reluctance of small hospitals to offer transplant drug monitoring assay services may hamper the market growth.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of transplant drug monitoring assay. The growth and trends of transplant drug monitoring assay industry provide a holistic approach to this study.

MARKET SEGMENTATION:

This section of the transplant drug monitoring assay market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product

• Equipment
• Consumables (Chromatography & Ms Detectors, Immunoassay Analyzers, Clinical Chemistry Analyzers)

By Technology

• Chromatography-Ms
• Immunoassays

By Drug

• Tacrolimus
• Methotrexate
• Cyclosporin
• Others

By End-User

• Hospital Laboratories
• Commercial & Private Laboratories
• Others

REGIONAL ANALYSIS:

This section covers the regional outlook, which accentuates current and future demand for the Transplant Drug Monitoring Assay market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Transplant Drug Monitoring Assay market include Abbott, Thermo Fisher Scientific Inc., H.U. Group Holdings Inc. (Fujirebio Holdings, Inc.), Hoffmann-La Roche Ltd., Siemens Healthineers AG, Hologic Inc., Danaher Corporation, Bio-Rad Laboratories Inc., Other prominent players. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1 . PREFACE

• 1.1. Report Description
  • 1.1.1. Objective
  • 1.1.2. Target Audience
  • 1.1.3. Unique Selling Proposition (USP) & offerings
• 1.2. Research Scope
• 1.3. Research Methodology
  • 1.3.1. Market Research Process
  • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

• 2.1. Highlights of Market
• 2.2. Global Market Snapshot

3 . TRANSPLANT DRUG MONITORING ASSAY - INDUSTRY ANALYSIS

• 3.1. Introduction - Market Dynamics
• 3.2. Market Drivers
• 3.3. Market Restraints
• 3.4. Opportunities
• 3.5. Industry Trends
• 3.6. Porter's Five Force Analysis
• 3.7. Market Attractiveness Analysis
  • 3.7.1 Market Attractiveness Analysis By Product
  • 3.7.2 Market Attractiveness Analysis By Technology
  • 3.7.3 Market Attractiveness Analysis By Drug
  • 3.7.4 Market Attractiveness Analysis By End-user
  • 3.7.5 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

• 4.1. Value Chain Analysis
• 4.2. Raw Material Analysis
  • 4.2.1. List of Raw Materials
  • 4.2.2. Raw Material Manufactures List
  • 4.2.3. Price Trend of Key Raw Materials
• 4.3. List of Potential Buyers
• 4.4. Marketing Channel
  • 4.4.1. Direct Marketing
  • 4.4.2. Indirect Marketing
  • 4.4.3. Marketing Channel Development Trend

5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK

6 . GLOBAL TRANSPLANT DRUG MONITORING ASSAY MARKET ANALYSIS BY PRODUCT

• 6.1 Overview by Product
• 6.2 Historical and Forecast Data
• 6.3 Analysis by Product
• 6.4 Equipment Historic and Forecast Sales by Regions
• 6.5 Consumables (Chromatography & MS Detectors, Immunoassay Analyzers, Clinical Chemistry Analyzers) Historic and Forecast Sales by Regions

7 . GLOBAL TRANSPLANT DRUG MONITORING ASSAY MARKET ANALYSIS BY TECHNOLOGY

• 7.1 Overview by Technology
• 7.2 Historical and Forecast Data
• 7.3 Analysis by Technology
• 7.4 Chromatography-MS Historic and Forecast Sales by Regions
• 7.5 Immunoassays Historic and Forecast Sales by Regions

8 . GLOBAL TRANSPLANT DRUG MONITORING ASSAY MARKET ANALYSIS BY DRUG

• 8.1 Overview by Drug
• 8.2 Historical and Forecast Data
• 8.3 Analysis by Drug
• 8.4 Tacrolimus Historic and Forecast Sales by Regions
• 8.5 Methotrexate Historic and Forecast Sales by Regions
• 8.6 Cyclosporin Historic and Forecast Sales by Regions
• 8.7 Others Historic and Forecast Sales by Regions

9 . GLOBAL TRANSPLANT DRUG MONITORING ASSAY MARKET ANALYSIS BY END-USER

• 9.1 Overview by End-user
• 9.2 Historical and Forecast Data
• 9.3 Analysis by End-user
• 9.4 Hospital Laboratories Historic and Forecast Sales by Regions
• 9.5 Commercial & Private Laboratories Historic and Forecast Sales by Regions
• 9.6 Others Historic and Forecast Sales by Regions

10 . GLOBAL TRANSPLANT DRUG MONITORING ASSAY MARKET ANALYSIS BY GEOGRAPHY

• 10.1. Regional Outlook
• 10.2. Introduction
• 10.3. North America Sales Analysis
  • 10.3.1. Overview, Historic and Forecast Sales Analysis
  • 10.3.2. North America By Segment Sales Analysis
  • 10.3.3. North America By Country Sales Analysis
  • 10.3.4. United State Sales Analysis
  • 10.3.5. Canada Sales Analysis
  • 10.3.6. Mexico Sales Analysis
• 10.4. Europe Sales Analysis
  • 10.4.1. Overview, Historic and Forecast Sales Analysis
  • 10.4.2. Europe by Segment Sales Analysis
  • 10.4.3. Europe by Country Sales Analysis
  • 10.4.4. United Kingdom Sales Analysis
  • 10.4.5. France Sales Analysis
  • 10.4.6. Germany Sales Analysis
  • 10.4.7. Italy Sales Analysis
  • 10.4.8. Russia Sales Analysis
  • 10.4.9. Rest Of Europe Sales Analysis
• 10.5. Asia Pacific Sales Analysis
  • 10.5.1. Overview, Historic and Forecast Sales Analysis
  • 10.5.2. Asia Pacific by Segment Sales Analysis
  • 10.5.3. Asia Pacific by Country Sales Analysis
  • 10.5.4. China Sales Analysis
  • 10.5.5. India Sales Analysis
  • 10.5.6. Japan Sales Analysis
  • 10.5.7. South Korea Sales Analysis
  • 10.5.8. Australia Sales Analysis
  • 10.5.9. Rest Of Asia Pacific Sales Analysis
• 10.6. Latin America Sales Analysis
  • 10.6.1. Overview, Historic and Forecast Sales Analysis
  • 10.6.2. Latin America by Segment Sales Analysis
  • 10.6.3. Latin America by Country Sales Analysis
  • 10.6.4. Brazil Sales Analysis
  • 10.6.5. Argentina Sales Analysis
  • 10.6.6. Peru Sales Analysis
  • 10.6.7. Chile Sales Analysis
  • 10.6.8. Rest of Latin America Sales Analysis
• 10.7. Middle East & Africa Sales Analysis
  • 10.7.1. Overview, Historic and Forecast Sales Analysis
  • 10.7.2. Middle East & Africa by Segment Sales Analysis
  • 10.7.3. Middle East & Africa by Country Sales Analysis
  • 10.7.4. Saudi Arabia Sales Analysis
  • 10.7.5. UAE Sales Analysis
  • 10.7.6. Israel Sales Analysis
  • 10.7.7. South Africa Sales Analysis
  • 10.7.8. Rest Of Middle East And Africa Sales Analysis

11 . COMPETITIVE LANDSCAPE OF THE TRANSPLANT DRUG MONITORING ASSAY COMPANIES

• 11.1. Transplant Drug Monitoring Assay Market Competition
• 11.2. Partnership/Collaboration/Agreement
• 11.3. Merger And Acquisitions
• 11.4. New Product Launch
• 11.5. Other Developments

12 . COMPANY PROFILES OF TRANSPLANT DRUG MONITORING ASSAY INDUSTRY

• 12.1. Top Company Share Analysis
• 12.2. Market Concentration Rate
• 12.3. Abbott
  • 12.3.1. Company Overview
  • 12.3.2. Company Revenue
  • 12.3.3. Products
  • 12.3.4. Recent Developments
• 12.4. Thermo Fisher Scientific Inc.
  • 12.4.1. Company Overview
  • 12.4.2. Company Revenue
  • 12.4.3. Products
  • 12.4.4. Recent Developments
• 12.5. H.U. Group Holdings Inc.
  • 12.5.1. Company Overview
  • 12.5.2. Company Revenue
  • 12.5.3. Products
  • 12.5.4. Recent Developments
• 12.6. Fujirebio Holdings Inc.
  • 12.6.1. Company Overview
  • 12.6.2. Company Revenue
  • 12.6.3. Products
  • 12.6.4. Recent Developments
• 12.7. Hoffmann-La Roche Ltd.
  • 12.7.1. Company Overview
  • 12.7.2. Company Revenue
  • 12.7.3. Products
  • 12.7.4. Recent Developments
• 12.8. Siemens Healthineers AG
  • 12.8.1. Company Overview
  • 12.8.2. Company Revenue
  • 12.8.3. Products
  • 12.8.4. Recent Developments
• 12.9. Hologic Inc.
  • 12.9.1. Company Overview
  • 12.9.2. Company Revenue
  • 12.9.3. Products
  • 12.9.4. Recent Developments
• 12.10. Danaher Corporation
  • 12.10.1. Company Overview
  • 12.10.2. Company Revenue
  • 12.10.3. Products
  • 12.10.4. Recent Developments
• 12.11. Bio-Rad Laboratories Inc.
  • 12.11.1. Company Overview
  • 12.11.2. Company Revenue
  • 12.11.3. Products
  • 12.11.4. Recent Developments
• 12.12. Other Prominent Players
  • 12.12.1. Company Overview
  • 12.12.2. Company Revenue
  • 12.12.3. Products
  • 12.12.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

LIST OF TABLES

• Market Snapshot
• Drivers : Impact Analysis
• Restraints : Impact Analysis
• List of Raw Material
• List of Raw Material Manufactures
• List of Potential Buyers
• Analysis by Product (USD MN)
• Equipment Market Sales by Geography (USD MN)
• Consumables (Chromatography & MS Detectors, Immunoassay Analyzers, Clinical Chemistry Analyzers) Market Sales by Geography (USD MN)
• Analysis Market by Technology (USD MN)
• Chromatography-MS Market Sales by Geography (USD MN)
• Immunoassays Market Sales by Geography (USD MN)
• Analysis by Drug (USD MN)
• Tacrolimus Market Sales by Geography (USD MN)
• Methotrexate Market Sales by Geography (USD MN)
• Cyclosporin Market Sales by Geography (USD MN)
• Others Market Sales by Geography (USD MN)
• Analysis by End-user (USD MN)
• Hospital Laboratories Market Sales by Geography (USD MN)
• Commercial & Private Laboratories Market Sales by Geography (USD MN)
• Others Market Sales by Geography (USD MN)
• Global Transplant Drug Monitoring Assay Market Sales by Geography (USD MN)
• North America Market Analysis (USD MN)
• United State Market Analysis (USD MN)
• Canada Market Analysis (USD MN)
• Mexico Market Analysis (USD MN)
• Europe Market Analysis (USD MN)
• Europe Market Estimate by Country (USD MN)
• United Kingdom Market Analysis (USD MN)
• France Market Analysis (USD MN)
• Germany Market Analysis (USD MN)
• Italy Market Analysis (USD MN)
• Russia Market Analysis (USD MN)
• Spain Market Analysis (USD MN)
• Rest of Europe Market Analysis (USD MN)
• Asia Pacific Market Analysis (USD MN)
• China Market Analysis (USD MN)
• Japan Market Analysis (USD MN)
• India Market Analysis (USD MN)
• South Korea Market Analysis (USD MN)
• Australia Market Analysis (USD MN)
• Rest of Asia Pacific Market Analysis (USD MN)
• Latin America Market Analysis (USD MN)
• Brazil Market Analysis (USD MN)
• Argentina Market Analysis (USD MN)
• Peru Market Analysis (USD MN)
• Chile Market Analysis (USD MN)
• Rest of Latin America Market Analysis (USD MN)
• Middle East & Africa Market Analysis (USD MN)
• Saudi Arabia Market Analysis (USD MN)
• UAE Market Analysis (USD MN)
• Israel Market Analysis (USD MN)
• South Africa Market Analysis (USD MN)
• Rest of Middle East and Africa Market Analysis (USD MN)
• Partnership/Collaboration/Agreement
• Mergers And Acquisition

LIST OF FIGURES

• Research Scope of Transplant Drug Monitoring Assay Report
• Market Research Process
• Market Research Methodology
• Global Transplant Drug Monitoring Assay Market Size, by Region (USD MN)
• Porters Five Forces Analysis
• Market Attractiveness Analysis by Product
• Market Attractiveness Analysis by Technology
• Market Attractiveness Analysis by Drug
• Market Attractiveness Analysis by End-user
• Market Attractiveness Analysis by Region
• Value Chain Analysis
• Global Market Analysis Product (USD MN)
• Equipment Market Sales by Geography (USD MN)
• Consumables (Chromatography & MS Detectors, Immunoassay Analyzers, Clinical Chemistry Analyzers) Market Sales by Geography (USD MN)
• Global Market Analysis by Technology (USD MN)
• Chromatography-MS Market Sales by Geography (USD MN)
• Immunoassays Market Sales by Geography (USD MN)
• Global Market Analysis by Drug (USD MN)
• Tacrolimus Market Sales by Geography (USD MN)
• Methotrexate Market Sales by Geography (USD MN)
• Cyclosporin Market Sales by Geography (USD MN)
• Others Market Sales by Geography (USD MN)
• Global Market Analysis by End-user (USD MN)
• Hospital Laboratories Market Sales by Geography (USD MN)
• Commercial & Private Laboratories Market Sales by Geography (USD MN)
• Others Market Sales by Geography (USD MN)
• Global Market by Revenue
• North America Market by Revenue
• Europe Market by Revenue
• Asia Pacific Market by Revenue
• Latin America Market by Revenue
• Middle East & Africa Market by Revenue
• Recent Development in Industry
• Top Company Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.